Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gen One Cig
AddedMar 20, 2024
UpdatedJun 18, 2026
Gen One Cig

Gen One Cig

Innovative healthcare company specializing in medical services.

HQ
Southfield, MI, US
Founded
2007
Overview
Compare
Fundraising
Employees

Gen One Cig operates in the healthcare sector. It specializes in the fields of healthcare, health diagnostics, and medical.

The company was incorporated in 2007 and is based in Southfield, Michigan.

Gen One Cig - Similar Companies

Geneicd logo

Geneicd

SenGenix logo

SenGenix

sengenix.com

OneOme logo

OneOme

oneome.com

Nexgen Medical Systems logo

Nexgen Medical Systems

Genetron Health logo

Genetron Health

genetronhealth.com

Neurogami Medical logo

Neurogami Medical

Novogiene logo

Novogiene

Genesis Medtech logo

Genesis Medtech

Gatc Canna logo

Gatc Canna

One Health Group logo

One Health Group

GoGenics logo

GoGenics

Genicon logo

Genicon

Evincis Bio logo

Evincis Bio

Geneticure logo

Geneticure

geneticure.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Gen One Cig - Quick Facts

Who are Gen One Cig's competitors?

Companies similar to Gen One Cig include Geneicd, SenGenix, OneOme and Nexgen Medical Systems.

When was Gen One Cig founded?

Gen One Cig was founded in 2007.

Where is Gen One Cig's headquarters located?

Gen One Cig's headquarters is located in Southfield, MI, US.

When was Gen One Cig's last funding round?

Gen One Cig's most recent funding round was for $2M (USD) in March 2014.

How much has Gen One Cig raised to-date?

As of Mar 3, 2014, Gen One Cig has raised a total of $15.6M (USD).

How many employees does Gen One Cig have?

Gen One Cig has 50 employees as of Feb 5, 2024.

Gen One Cig - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Services
Tags
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified